In our work, we calculated the correlation between FDX1 expression and tumor immunity in ccRCC, and found that the FDX1low subgroup led to an immune hot phenotype, while immune impressive signatures were also high in this subtype. The gene discussed is FDX1; the disease is neoplasm.